Biopharmaceutical Analysis & Statistics, January 2013 (p5)

Brazil Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn

$ 250
Industry data
January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Industries : Biopharmaceutical
Countries : Brazil

Canada Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn

$ 250
Industry data
January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Industries : Biopharmaceutical
Countries : Canada

Colombia Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn

$ 250
Industry data
January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Industries : Biopharmaceutical
Countries : Colombia

Egypt Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn

$ 250
Industry data
January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Industries : Biopharmaceutical
Countries : Egypt

Guatemala Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn

$ 250
Industry data
January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Industries : Biopharmaceutical
Countries : Guatemala

India Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn

$ 250
Industry data
January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Industries : Biopharmaceutical
Countries : India

Ireland Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn

$ 250
Industry data
January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Industries : Biopharmaceutical
Countries : Ireland

Croatia Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn

$ 250
Industry data
January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Industries : Biopharmaceutical
Countries : Croatia

Czech Republic Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn

$ 250
Industry data
January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Industries : Biopharmaceutical
Countries : Czech Republic

Argentina Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn

$ 250
Industry data
January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Industries : Biopharmaceutical
Countries : Argentina

Intercell AG (Symbol:ICLL) SWOT Analysis, Strategy, Revenues and Profits

$ 125
Company report
March 2013
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Biopharmaceutical

Genmab AS (Symbol:GEN) SWOT Analysis, Strategy, Revenues and Profits

$ 125
Company report
March 2013
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Biopharmaceutical
Countries : United States

Amorfix Life Sciences Ltd. (Symbol:AMF) SWOT Analysis, Strategy, Revenues and Profits

$ 125
Company report
March 2013
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Biopharmaceutical

Keryx Biopharmaceuticals, Inc. (Symbol:KERX) SWOT Analysis, Strategy, Revenues and Profits

$ 125
Company report
March 2013
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Biopharmaceutical

ImClone LLC - Strategic SWOT Analysis Review

$ 125
Company report
March 2013
by Global Data

Summary ImClone LLC (ImClone) is a biopharmaceutical company. It undertakes the development and manufacturing of targeted biologic treatments for cancer. The company's product pipeline has several investigational ...

Industries : Biopharmaceutical
Countries : United States

Vical Incorporated (Symbol:VICL) SWOT Analysis, Strategy, Revenues and Profits

$ 125
Company report
March 2013
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Biopharmaceutical
Countries : United States

Cangene Corporation (Symbol:CNJ) SWOT Analysis, Strategy, Revenues and Profits

$ 125
Company report
March 2013
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Biopharmaceutical

Great Wall Enterprise Co., Ltd. - Company Capsule

$ 99
Company report
May 2013
by Canadean Ltd

Synopsis Canadean's "Great Wall Enterprise Co., Ltd. - Company Capsule" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, ...

Industries : Livestock, Biopharmaceutical
Countries : Taiwan

NVO - Kalundborg New Biopharmaceutical Production Facility - Denmark - Construction Project Profile

$ 75
Industry report
April 2013
by World Market Intelligence Ltd

Synopsis The NVO - Kalundborg New Biopharmaceutical Production Facility - Denmark - Construction Project Profile contains information on the scope of the project including project overview and location. ...

Industries : Biopharmaceutical
Countries : Denmark

The Contract Biomanufacturing Market Outlook to 2017

$ 3 500
Industry report
February 2013
by Datamonitor

Introduction The volume demand for biologics active pharmaceutical ingredients (API) from 2011-2017 is set to show a 20% annual increase. Combined with a boost in biosimilars, the biologics contract manufacturing ...

Industries : Biopharmaceutical

Sports Nutrition Market Analysis in Mexico

$ 898
Industry report
February 2013
by Euromonitor International

According to market sources, while pirate products are very few, counterfeits accounted for over 50% of all products consumed in Mexico. This flooding of counterfeits forced domestic established businesses ...

Industries : Sport Nutritional, Biopharmaceutical
Countries : Mexico

Sports Nutrition Market Analysis in the United Arab Emirates

$ 898
Industry report
February 2013
by Euromonitor International

With sports nutrition products considered luxuries and not necessities, the performance of the category was negatively affected by the fallout from the economic downturn. Many consumers cut their purchases ...

Industries : Sport Nutritional, Biopharmaceutical
Countries : United Arab Emirates

XTL Biopharmaceuticals Ltd. (XTLBY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$ 250
Company report
February 2013
by Global Data

Summary XTL Biopharmaceuticals Ltd. (XTL) is a biotechnology company, based in Israel. The company acquires, develops and commercializes therapeutics for the treatment of multiple myeloma and hepatitis ...

Industries : Biopharmaceutical
Countries : Israel

XERIS Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$ 250
Company report
February 2013
by Global Data

Summary XERIS Pharmaceuticals, Inc. (XERIS) is a privately held development stage biopharmaceutical company. It is in the development of injectables for the treatment of endocrine and metabolic diseases. ...

Industries : Biopharmaceutical
Countries : United States

Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 - Market Characterized by Large and Diversified Pipeline and Low Threat of Biosimilar Sales Erosion

$ 3 500
Industry report
January 2013
by GBI Research

Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 - Market Characterized by Large and Diversified Pipeline and Low Threat of Biosimilar Sales Erosion Summary GBI Research, the leading business ...

Industries : Biopharmaceutical
Countries : World

Enzon Pharmaceuticals, Inc. : Pharmaceuticals and Healthcare - Company Profile, SWOT and Financial Report

$ 125
Company report
January 2013
by ICD Research

Synopsis ICD Research's "Enzon Pharmaceuticals, Inc. : Pharmaceuticals and Healthcare - Company Profile, SWOT and Financial Report" contains in depth information and data about the company and its operations. ...

Industries : Biopharmaceutical
Countries : United States

ImmunoGen, Inc. : Pharmaceuticals and Healthcare - Company Profile, SWOT and Financial Report

$ 125
Company report
January 2013
by ICD Research

Synopsis ICD Research's "ImmunoGen, Inc. : Pharmaceuticals and Healthcare - Company Profile, SWOT and Financial Report" contains in depth information and data about the company and its operations. The ...

Industries : Biopharmaceutical
Countries : United States

REVOTAR Biopharmaceuticals AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$ 250
Company report
January 2013
by Global Data

Summary REVOTAR Biopharmaceuticals AG (REVOTAR) is a privately held biopharmaceutical company. The company is involved in the research and development of anti-inflammatory drugs for the conditions such ...

Industries : Biopharmaceutical

Selexis SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$ 250
Company report
January 2013
by Global Data

Summary Selexis SA (Selexis) is a biotechnology company that develops innovative technologies for cell line development and drug discovery. The company's technology helps in developing high-performance ...

Industries : Biopharmaceutical
Countries : Switzerland

Syntarga BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$ 250
Company report
January 2013
by Global Data

Summary Syntarga B.V. (Syntarga) is a biopharmaceutical company, based in the Netherlands. The company creates chemistries to link anticancer activity to specificity. It develops highly potent cell-killing ...

Industries : Biopharmaceutical
Countries : Netherlands

Merger & Acquisition in Pharmaceuticals & Healthcare Industry: Sino Biopharmaceutical Limited (1177)

$ 250
Company report
January 2013
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Biopharmaceutical
Countries : China

Repligen Corporation (RGEN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$ 250
Company report
January 2013
by Global Data

Summary Repligen Corporation (Repligen) is a biopharmaceutical company indulged in discovery, development and commercialization of novel therapeutics in the areas of neurology and gastroenterology. The ...

Industries : Biopharmaceutical
Countries : United States

Scil Proteins GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$ 250
Company report
January 2013
by Global Data

Summary Scil Proteins GmbH (Scil) is a privately held Germany-based pharmaceutical company. It engages in discovering, developing and producing recombinant protein products. The company's are carried out ...

Industries : Biopharmaceutical

R&D Biopharmaceuticals GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$ 250
Company report
January 2013
by Global Data

Summary R&D Biopharmaceuticals GmbH (R&D-Biopharmaceuticals) is a biotechnology company, based in Germany. The company centers on pre-clinical and clinical development of unique small molecules deriving ...

Industries : Biopharmaceutical
Countries : Germany

Prima BioMed Limited (PRR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$ 250
Company report
January 2013
by Global Data

Summary Prima BioMed Limited (Prima) is a biotechnology company, based in Australia. The company develops anti-cancer therapeutics based on the emerging technology of immunotherapy. Its lead products HPV ...

Industries : Biopharmaceutical
Countries : Australia

Saamya Biotech (India) Ltd. (532905) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$ 250
Company report
January 2013
by Global Data

Summary Saamya Biotech (India) Ltd. is a Biotechnology company. The company is engaged in manufacturing biopharmaceuticals and recombinant protein products. It is headquartered in Andhra Pradesh, India. ...

Industries : Biopharmaceutical
Countries : India

Protein Discovery, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$ 250
Company report
January 2013
by Global Data

Summary Protein Discovery, Inc. (Protein Discovery) is a diagnostics company, engaged in the research, development and commercializing of sample preparation technologies for the in vitro diagnostic markets. ...

Industries : Biopharmaceutical
Countries : United States

Merger & Acquisition in Pharmaceuticals & Healthcare Industry: ProMetic Life Sciences Inc. (PLI)

$ 250
Company report
January 2013
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Biopharmaceutical
Countries : United States, Canada

RegeneRx Biopharmaceuticals, Inc. (RGRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$ 250
Company report
January 2013
by Global Data

Summary RegeneRx Biopharmaceuticals, Inc. (RegeneRx Biopharmaceuticals) is a biopharmaceutical company, based in the US. It provides research facilities for vaccine discovery for treatment of diseases ...

Industries : Biopharmaceutical
Countries : United States

Redbiotec AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$ 250
Company report
January 2013
by Global Data

Summary Redbiotec AG (Redbiotec) is a bio-pharmaceutical company engaged in offering a wide range of products to effectively combat infectious diseases. Its product portfolio includes biologics such as ...

Industries : Biopharmaceutical